Drug-mediated inhibition of Fli-1 for the treatment of leukemia
Li, Y-J; Zhao, X.; Vecchiarelli-Federico, L. M.1; Li, Y.; Datti, A.2,3; Cheng, Y.4; Ben-David, Y.1
2012
发表期刊BLOOD CANCER JOURNAL
ISSN2044-5385
卷号2页码:e54
摘要The Ets transcription factor, Fli-1 is activated in murine erythroleukemia and overexpressed in various human malignancies including Ewing's sarcoma, induced by the oncogenic fusion protein EWS/Fli-1. Recent studies by our group and others have demonstrated that Fli-1 plays a key role in tumorigenesis, and disrupting its oncogenic function may serve as a potential treatment option for malignancies associated with its overexpression. Herein, we describe the discovery of 30 anti-Fli-1 compounds, characterized into six functional groups. Treatment of murine and human leukemic cell lines with select compounds inhibits Fli-1 protein or mRNA expression, resulting in proliferation arrest and apoptosis. This anti-cancer effect was mediated, at least in part through direct inhibition of Fli-1 function, as anti-Fli-1 drug treatment inhibited Fli-1 DNA binding to target genes, such as SHIP-1 and gata-1, governing hematopoietic differentiation and proliferation. Furthermore, treatment with select Fli-1 inhibitors revealed a positive relationship between the loss of DNA-binding activity and Fli-1 phosphorylation. Accordingly, anti-Fli-1 drug treatment significantly inhibited leukemogenesis in a murine erythroleukemia model overexpressing Fli-1. This study demonstrates the ability of this drug-screening strategy to isolate effective anti-Fli-1 inhibitors and highlights their potential use for the treatment of malignancies overexpressing this oncogene.
关键词Erythroleukemia Fli-1 Drug Inhibition
资助信息Ontario Institute for Cancer Research (OICR); Canadian Institute of Health Research (CIHR)[MOP-110952]
收录类别SCI
语种英语
引用统计
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/10393
专题植物化学与西部植物资源持续利用国家重点实验室
作者单位1.Univ Toronto, Dept Med Biophys, Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
2.Mt Sinai Hosp, Samuel Lunenfeld Res Inst, SMART Facil, Toronto, ON M5G 1X5, Canada
3.Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy
4.Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China
推荐引用方式
GB/T 7714
Li, Y-J,Zhao, X.,Vecchiarelli-Federico, L. M.,et al. Drug-mediated inhibition of Fli-1 for the treatment of leukemia[J]. BLOOD CANCER JOURNAL,2012,2:e54.
APA Li, Y-J.,Zhao, X..,Vecchiarelli-Federico, L. M..,Li, Y..,Datti, A..,...&Ben-David, Y..(2012).Drug-mediated inhibition of Fli-1 for the treatment of leukemia.BLOOD CANCER JOURNAL,2,e54.
MLA Li, Y-J,et al."Drug-mediated inhibition of Fli-1 for the treatment of leukemia".BLOOD CANCER JOURNAL 2(2012):e54.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Li-2012-Drug-mediate(618KB) 开放获取--请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, Y-J]的文章
[Zhao, X.]的文章
[Vecchiarelli-Federico, L. M.]的文章
百度学术
百度学术中相似的文章
[Li, Y-J]的文章
[Zhao, X.]的文章
[Vecchiarelli-Federico, L. M.]的文章
必应学术
必应学术中相似的文章
[Li, Y-J]的文章
[Zhao, X.]的文章
[Vecchiarelli-Federico, L. M.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。